Skip to main content
. Author manuscript; available in PMC: 2010 Jul 19.
Published in final edited form as: Neuroscience. 2008 Feb 21;153(1):162–174. doi: 10.1016/j.neuroscience.2008.02.018

Fig. 2.

Fig. 2

Validation of the polyclonal antibody against NDCBE. (A) Western blotting of N-termini of NBCn1, NDCBE, and NBCn2 (i.e., NCBE). (B) Western blotting of membrane preparations from oocytes expressing full-length transporter NDCBE-EGFP, NBCn1-B-EGFP, NBCn2-B-EGFP, or oocytes injected with H2O. (C) Western blotting of membrane preparations from oocytes expressing NDCBE-EGFP, NBCn2-B-EGFP, NBCe1-A-EGFP, EGFP-NBCe2, or oocytes injected with H2O.